Overview

Efficacy of Bifeprunox in Patients With Schizophrenia

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to evaluate the efficacy of bifeprunox in the maintenance phase of schizophrenia compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Quetiapine Fumarate